Nasacort AQ

Nasacort AQ Overdosage

triamcinolone acetonide

Manufacturer:

sanofi-aventis

Distributor:

DKSH
Full Prescribing Info
Overdosage
Like any other nasally administered corticosteroid, acute overdosing is unlikely in view of the total amount of active ingredient present. In the event that the entire contents of the bottle were administered all at once, via either oral or nasal application, clinically significant systemic adverse events would most likely not result. The patient may experience some gastrointestinal upset.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in